Ozempic and Other GLP‑1 Drugs: All Hype or Actually Helpful?
Diabetes drugs being used for weight loss have gained attention as potential allies in the battle against obesity. With a staggering 42% of adults grappling with obesity, the GLP‑1 receptor agonists have emerged as a promising trend. In addition, adults with diabetes incur medical expenditures of $16,750 per year on average.
How can employers cope with these costs and enhance employee health? Are GLP‑1 drugs helpful or just a lot of hype?
Discover benefits and trade-offs of covering GLP‑1 drugs for weight loss and smart strategies for diabetes management.
Speak to one of our Health Strategists
Fill out this contact form and we will schedule an ideal time to hear what's on your mind.